SGRY Q3 Deep Dive: Guidance Cut Highlights Volume and M&A Timing Pressures

Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Streets revenue expectations in Q3 CY2025, with sales up 6.6% year ...